WHWK insider trading
NasdaqCM HealthcareWhitehawk Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Company website: ir.whitehawktx.com
WHWK insider activity at a glance
FilingIQ has scored 34 insider transactions for WHWK since Dec 1, 2025. The most recent filing in our index is dated May 12, 2026.
Across the full history, 0 open-market purchases
and 14 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on WHWK insider trades is 65.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest WHWK Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading WHWK
13F funds holding WHWK
Frequently asked
- How many insider trades does FilingIQ track for WHWK?
- FilingIQ tracks 34 Form 4 insider transactions for WHWK (Whitehawk Therapeutics, Inc.), covering filings from Dec 1, 2025 onwards. 32 of those were filed in the last 90 days.
- Are WHWK insiders net buyers or net sellers?
- Across the full Form 4 history for WHWK, 0 transactions (0%) were open-market purchases and 14 (41%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does WHWK insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is WHWK in?
- Whitehawk Therapeutics, Inc. (WHWK) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $165.66M.
Methodology & sources
Every WHWK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.